ProfoundBio is an industry leader in Antibody-Drug Conjugates (ADC) technology and its applications in the treatment of cancer. We develop next generation novel proprietary drug linker technology harnessing the targeting power of antibodies to deliver small molecule drugs to the for improved efficacy and tolerability.